See more : Lens Technology Co., Ltd. (300433.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of CareMax, Inc. (CMAX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareMax, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Regeneron Pharmaceuticals, Inc. (REGN) Income Statement Analysis – Financial Results
- Winners, Inc. (WNRS) Income Statement Analysis – Financial Results
- Singapore Post Limited (SPSTY) Income Statement Analysis – Financial Results
- Millennial Precious Metals Corp. (MLPMF) Income Statement Analysis – Financial Results
- ESM Acquisition Corporation (ESM-WT) Income Statement Analysis – Financial Results
CareMax, Inc. (CMAX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.caremax.com
About CareMax, Inc.
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 751.10M | 631.13M | 295.76M | 103.42M | 90.60M | 72.38M |
Cost of Revenue | 737.20M | 550.83M | 264.31M | 83.42M | 51.62M | 44.16M |
Gross Profit | 13.90M | 80.30M | 31.45M | 20.00M | 38.98M | 28.22M |
Gross Profit Ratio | 1.85% | 12.72% | 10.63% | 19.34% | 43.02% | 38.99% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 80.68M | 75.82M | 40.58M | 7.75M | 11.56M | 23.53M |
Selling & Marketing | 14.27M | 11.76M | 4.96M | 1.07M | 20.85M | 1.21M |
SG&A | 94.96M | 87.59M | 45.53M | 8.82M | 32.41M | 24.74M |
Other Expenses | 575.10M | 21.72M | 13.22M | 1.50M | 0.00 | 0.00 |
Operating Expenses | 670.05M | 109.30M | 58.75M | 10.32M | 32.41M | 24.74M |
Cost & Expenses | 1.41B | 660.13M | 323.06M | 93.74M | 84.04M | 68.90M |
Interest Income | 0.00 | 20.24M | 4.49M | 1.66M | 720.40K | 0.00 |
Interest Expense | 54.43M | 20.24M | 4.49M | 1.66M | 0.00 | 0.00 |
Depreciation & Amortization | 39.31M | 21.72M | 13.22M | 1.50M | 975.90K | 602.85K |
EBITDA | -590.46M | -15.38M | 11.19M | 11.18M | 7.54M | 4.09M |
EBITDA Ratio | -78.61% | -1.07% | -11.80% | 10.81% | 8.32% | 5.65% |
Operating Income | -656.15M | -29.00M | -27.30M | 9.68M | 6.57M | 3.49M |
Operating Income Ratio | -87.36% | -4.60% | -9.23% | 9.36% | 7.25% | 4.82% |
Total Other Income/Expenses | -28.06M | -28.34M | 22.31M | -2.11M | -720.40K | 0.00 |
Income Before Tax | -684.21M | -57.34M | -6.52M | 7.57M | 5.85M | 3.49M |
Income Before Tax Ratio | -91.09% | -9.09% | -2.20% | 7.32% | 6.45% | 4.82% |
Income Tax Expense | -863.00K | -19.54M | 159.00K | 1.63M | -173.19K | 16.47K |
Net Income | -683.35M | -37.80M | -6.68M | 5.94M | 6.02M | 3.47M |
Net Income Ratio | -90.98% | -5.99% | -2.26% | 5.75% | 6.64% | 4.79% |
EPS | -183.30 | -12.49 | -3.90 | 16.42 | 0.00 | 9.54 |
EPS Diluted | -183.30 | -12.49 | -3.81 | 16.51 | 0.00 | 9.64 |
Weighted Avg Shares Out | 3.73M | 3.03M | 1.71M | 361.95K | 0.00 | 363.66K |
Weighted Avg Shares Out (Dil) | 3.73M | 3.03M | 1.75M | 359.87K | 0.00 | 359.87K |
CareMax Strategy Faces High Initial MER Costs
CareMax to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
CareMax, Inc. (CMAX) Q2 2023 Earnings Call Transcript
CareMax, Inc. (CMAX) Reports Q2 Loss, Tops Revenue Estimates
CareMax Reports Second Quarter 2023 Results
CareMax Schedules Second Quarter 2023 Earnings Conference Call
CareMax: Reiterate Buy On Potential Future Growth
CareMax to Present at the Jefferies Healthcare Conference
CareMax, Inc. (CMAX) Q1 2023 Earnings Call Transcript
CareMax, Inc. (CMAX) Reports Q1 Loss, Lags Revenue Estimates
Source: https://incomestatements.info
Category: Stock Reports